We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi Halts Trial of Kidney Disease Treatment
Sanofi announced that it has halted its trial of drug candidate venglustat for the treatment of autosomal dominant polycystic kidney disease, or ADPKD, following disappointing results.